# Johnson & Johnson (JNJ) insider trading and SEC filings

Johnson & Johnson (JNJ) insider trades from SEC Form 4s: who traded, the transaction and the share count, each linked to EDGAR.

I read the 8 insider filings below, filed between Aug 7 and Sep 10, 2026, on Forms 3 and 4. Each one is about Johnson & Johnson stock and links to the original on EDGAR. They name 7 insiders: 3 directors and 4 officers. Of the filings, 4 report an open-market sale and 3 an option exercise (some filings report more than one type). In 3 of the 4 filings reporting a sale, the same person also reports an option exercise on the same trade date. Johnson & Johnson's SEC record shows its latest 10-K filed Feb 11, 2026, its latest 10-Q Jul 23, 2026, and its latest 8-K Aug 4, 2026.

| Form | Filed | Insider | Transaction | Price | Trade date | Shares held after | Ownership |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 4 | 2026-09-10 | Pinto Daniel E — Director | not itemised — see the filing | — | — | — | — |
| 4 | 2026-09-10 | Woods Eugene A. — Director | not itemised — see the filing | — | — | — | — |
| 4 | 2026-09-10 | HEWSON MARILLYN A — Director | not itemised — see the filing | — | — | — | — |
| 4 | 2026-09-04 | Timothy Schmid — EVP, WW Chair, MedTech | Option exercise · 33,597 shares (across 2 transactions) | $131.94-$151.41 | Sep 2, 2026 | 47,974 | Direct |
| 4 | 2026-09-04 | Timothy Schmid — EVP, WW Chair, MedTech | Open-market sale · 33,597 shares (across 2 transactions) | $274.74 | Sep 2, 2026 | 25,447 | Direct |
| 3 | 2026-09-01 | Thomas Cavanaugh — EVP WW Chair, Innovative Med. | Initial statement of holdings | — | — | — | — |
| 4 | 2026-08-18 | Taubert Jennifer L — EVP, WWC. Innovative Medicine | Option exercise · 15,000 shares | $115.67 | Aug 17, 2026 | 209,451 | Direct |
| 4 | 2026-08-18 | Taubert Jennifer L — EVP, WWC. Innovative Medicine | Open-market sale · 15,000 shares | $263.36 | Aug 17, 2026 | 194,451 | Direct |
| 4 | 2026-08-14 | Joaquin Duato — CEO and Chairman of the Board | Option exercise · 123,291 shares | $115.67 | Aug 13, 2026 | 399,258 | Direct |
| 4 | 2026-08-14 | Joaquin Duato — CEO and Chairman of the Board | Open-market sale · 123,291 shares (across 2 transactions) | $261.00-$262.00 | Aug 13, 2026 | 275,967 | Direct |
| 4 | 2026-08-07 | Joaquin Duato — CEO and Chairman of the Board | Open-market sale · 48,480 shares (across 2 transactions) | $258.056-$258.739 | Aug 5, 2026 | 275,967 | Direct |

Source: [https://pipthebot.com/insider/jnj/](https://pipthebot.com/insider/jnj/)

Pip is for research and education only — not investment advice, and not a recommendation to buy, sell, or hold any security. Pip reflects your own stated reasons against public information and never tells you what to do. You decide.